Benzinga's Top Initiations

Analysts at Credit Suisse initiated coverage on shares of New Home Company NWHM with an “outperform” rating. The target price for New Home Company is set to $16. New Home Company's shares closed at $12.65 yesterday. Morgan Stanley initiated coverage on shares of Ultragenyx Pharmaceutical RARE with an “overweight” rating. The target price for Ultragenyx is set to $81. Ultragenyx's shares closed at $58.01 yesterday. Analysts at JP Morgan initiated coverage on shares of Verizon Communications VZ with an “overweight” rating. The target price for Verizon is set to $57. Verizon's shares closed at $46.23 yesterday. Stifel Nicolaus initiated coverage on shares of Cara Therapeutics CARA with a “buy” rating. The target price for Cara Therapeutics is set to $21. Cara Therapeutics' shares closed at $14.48 yesterday.